Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 574

1.

Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: A spatial analysis.

Amram O, Socías E, Nosova E, Kerr T, Wood E, DeBeck K, Hayashi K, Fairbairn N, Montaner J, Milloy MJ.

Spat Spatiotemporal Epidemiol. 2019 Aug;30:100288. doi: 10.1016/j.sste.2019.100288. Epub 2019 Jul 4.

PMID:
31421798
2.

Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada.

Pilarinos A, Barker B, Nosova E, Milloy MJ, Hayashi K, Wood E, Kerr T, DeBeck K.

Addiction. 2019 Aug 4. doi: 10.1111/add.14769. [Epub ahead of print]

PMID:
31379008
3.

Trajectories of injection drug use among people who use drugs in Vancouver, Canada, 1996-2017: growth mixture modeling using data from prospective cohort studies.

Dong H, Hayashi K, Singer J, Milloy MJ, DeBeck K, Wood E, Kerr T.

Addiction. 2019 Jul 22. doi: 10.1111/add.14756. [Epub ahead of print]

PMID:
31328354
4.

Factors associated with willingness to wear an electronic overdose detection device.

Ahamad K, Dong H, Johnson C, Hyashi K, DeBeck K, Milloy MJ, Wood E.

Addict Sci Clin Pract. 2019 Jul 3;14(1):23. doi: 10.1186/s13722-019-0153-5.

5.

Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada.

Moallef S, Nosova E, Milloy MJ, DeBeck K, Fairbairn N, Wood E, Kerr T, Hayashi K.

Public Health Rep. 2019 Jul/Aug;134(4):423-431. doi: 10.1177/0033354919857084. Epub 2019 Jun 18.

PMID:
31211644
6.

Development and Evaluation of the Online Addiction Medicine Certificate: Free Novel Program in a Canadian Setting.

Gorfinkel LR, Giesler A, Dong H, Wood E, Fairbairn N, Klimas J.

JMIR Med Educ. 2019 May 24;5(1):e12474. doi: 10.2196/12474.

7.

Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain: A Systematic Review.

Klimas J, Gorfinkel L, Fairbairn N, Amato L, Ahamad K, Nolan S, Simel DL, Wood E.

JAMA Netw Open. 2019 May 3;2(5):e193365. doi: 10.1001/jamanetworkopen.2019.3365.

8.

Prevalence and correlates of selling illicit cannabis among people who use drugs in Vancouver, Canada: A ten-year prospective cohort study.

Reddon H, Fast D, DeBeck K, Werb D, Hayashi K, Wood E, Milloy MJ.

Int J Drug Policy. 2019 Jul;69:16-23. doi: 10.1016/j.drugpo.2019.02.006. Epub 2019 Apr 20.

PMID:
31015080
9.

Slow release oral morphine versus methadone for the treatment of opioid use disorder.

Klimas J, Gorfinkel L, Giacomuzzi SM, Ruckes C, Socías ME, Fairbairn N, Wood E.

BMJ Open. 2019 Apr 2;9(4):e025799. doi: 10.1136/bmjopen-2018-025799.

10.

Homelessness and incarceration associated with relapse into stimulant and opioid use among youth who are street-involved in Vancouver, Canada.

Goldman-Hasbun J, Nosova E, Kerr T, Wood E, DeBeck K.

Drug Alcohol Rev. 2019 May;38(4):428-434. doi: 10.1111/dar.12921. Epub 2019 Mar 21.

PMID:
30896070
11.

In-hospital training in addiction medicine: A mixed-methods study of health care provider benefits and differences.

Gorfinkel L, Klimas J, Reel B, Dong H, Ahamad K, Fairgrieve C, McLean M, Mead A, Nolan S, Small W, Cullen W, Wood E, Fairbairn N.

Subst Abus. 2019 Jan 28:1-7. doi: 10.1080/08897077.2018.1561596. [Epub ahead of print]

PMID:
30689528
12.

Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.

Socías ME, Ti L, Wood E, Nosova E, Hull M, Hayashi K, Debeck K, Milloy MJ.

Liver Int. 2019 Aug;39(8):1400-1407. doi: 10.1111/liv.14043. Epub 2019 Feb 24.

PMID:
30653809
13.

Lacking evidence for the association between frequent urine drug screening and health outcomes of persons on opioid agonist therapy.

McEachern J, Adye-White L, Priest KC, Moss E, Gorfinkel L, Wood E, Cullen W, Klimas J.

Int J Drug Policy. 2019 Feb;64:30-33. doi: 10.1016/j.drugpo.2018.08.006. Epub 2018 Dec 12.

PMID:
30551003
14.

Correction: Disparities in the Burden of HIV/AIDS in Canada.

Hogg RS, Heath K, Lima VD, Nosyk B, Kanters S, Wood E, Kerr T, Montaner JSG.

PLoS One. 2018 Dec 6;13(12):e0209045. doi: 10.1371/journal.pone.0209045. eCollection 2018.

15.

Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review.

Knight R, Karamouzian M, Carson A, Edward J, Carrieri P, Shoveller J, Fairbairn N, Wood E, Fast D.

Drug Alcohol Depend. 2019 Jan 1;194:410-429. doi: 10.1016/j.drugalcdep.2018.09.023. Epub 2018 Nov 3.

PMID:
30502543
16.

Large Variation in Provincial Guidelines for Urine Drug Screening during Opioid Agonist Treatment in Canada.

Moss E, McEachern J, Adye-White L, Priest KC, Gorfinkel L, Wood E, Cullen W, Klimas J.

Can J Addict. 2018 Jun;9(2):6-9. doi: 10.1097/CXA.0000000000000015.

17.

Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.

Bozinoff N, DeBeck K, Milloy MJ, Nosova E, Fairbairn N, Wood E, Hayashi K.

Drug Alcohol Depend. 2018 Dec 1;193:42-47. doi: 10.1016/j.drugalcdep.2018.09.003. Epub 2018 Oct 6.

PMID:
30340144
18.

The relationship between parental heavy drinking and non-fatal overdose among people who inject drugs in Vancouver, Canada.

Prangnell A, Nosova E, Milloy MJ, Wood E, Hayashi K.

Addict Behav. 2019 Feb;89:224-228. doi: 10.1016/j.addbeh.2018.08.016. Epub 2018 Aug 15.

PMID:
30326463
19.

Engagement in Maximally-Assisted Therapy and Adherence to Antiretroviral Therapy Among a Cohort of Indigenous People Who Use Illicit Drugs.

Barker B, Adams E, Wood E, Kerr T, DeBeck K, Dong H, Shoveller J, Montaner J, Milloy MJ.

AIDS Behav. 2019 May;23(5):1258-1266. doi: 10.1007/s10461-018-2226-y.

PMID:
30269233
20.

Regular MDMA use is associated with decreased risk of drug injection among street-involved youth who use illicit drugs.

Gaddis A, Lake S, Tupper K, Nosova E, Blommaert K, Wood E, DeBeck K.

Drug Alcohol Depend. 2018 Nov 1;192:112-117. doi: 10.1016/j.drugalcdep.2018.07.035. Epub 2018 Sep 12.

PMID:
30245459
21.

Diagnosing opioid addiction in people with chronic pain.

Gorfinkel L, Voon P, Wood E, Klimas J.

BMJ. 2018 Sep 21;362:k3949. doi: 10.1136/bmj.k3949. No abstract available.

PMID:
30242012
22.

High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.

Socías ME, Wood E, Lake S, Nolan S, Fairbairn N, Hayashi K, Shulha HP, Liu S, Kerr T, Milloy MJ.

Addiction. 2018 Dec;113(12):2250-2258. doi: 10.1111/add.14398. Epub 2018 Sep 20.

PMID:
30238568
23.

Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.

Ladak F, Socias E, Nolan S, Dong H, Kerr T, Wood E, Montaner J, Milloy MJ.

Antivir Ther. 2019;24(1):19-25. doi: 10.3851/IMP3265.

PMID:
30230474
24.

Will This Hospitalized Patient Develop Severe Alcohol Withdrawal Syndrome?: The Rational Clinical Examination Systematic Review.

Wood E, Albarqouni L, Tkachuk S, Green CJ, Ahamad K, Nolan S, McLean M, Klimas J.

JAMA. 2018 Aug 28;320(8):825-833. doi: 10.1001/jama.2018.10574. Review. Erratum in: JAMA. 2019 Jul 23;322(4):369.

PMID:
30167704
25.

Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.

Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E.

Drug Alcohol Depend. 2018 Sep 1;190:242-245. doi: 10.1016/j.drugalcdep.2018.06.020. Epub 2018 Jul 24.

PMID:
30064061
26.

Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada.

Jutras-Aswad D, Le Foll B, Bruneau J, Wild TC, Wood E, Fischer B.

Can J Psychiatry. 2019 Feb;64(2):82-87. doi: 10.1177/0706743718790955. Epub 2018 Jul 22. No abstract available.

27.

Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada.

Vipler S, Hayashi K, Milloy MJ, Wood E, Nosova E, Kerr T, Ti L.

Subst Abuse Treat Prev Policy. 2018 Jul 5;13(1):27. doi: 10.1186/s13011-018-0164-3.

28.

Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada.

Young S, Wood E, Milloy MJ, DeBeck K, Dobrer S, Nosova E, Kerr T, Hayashi PhD K.

Subst Abus. 2018;39(4):461-468. doi: 10.1080/08897077.2018.1485128. Epub 2018 Oct 2.

PMID:
29949450
29.

Linking opioid-induced hyperalgesia and withdrawal-associated injury site pain: a case report.

Rieb LM, Norman WV, Martin RE, Berkowitz J, Wood E, Milloy MJ, McNeil R.

Pain Rep. 2018 Apr 5;3(3):e648. doi: 10.1097/PR9.0000000000000648. eCollection 2018 May.

30.

Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.

Socías ME, Wood E, Kerr T, Nolan S, Hayashi K, Nosova E, Montaner J, Milloy MJ.

Drug Alcohol Depend. 2018 Aug 1;189:90-95. doi: 10.1016/j.drugalcdep.2018.04.026. Epub 2018 May 29.

31.

Strategies for Reducing Opioid-Overdose Deaths - Lessons from Canada.

Wood E.

N Engl J Med. 2018 Apr 26;378(17):1565-1567. doi: 10.1056/NEJMp1800216. No abstract available.

32.

The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.

Socias ME, Ahamad K, Le Foll B, Lim R, Bruneau J, Fischer B, Wild TC, Wood E, Jutras-Aswad D.

Contemp Clin Trials. 2018 Jun;69:21-27. doi: 10.1016/j.cct.2018.04.001. Epub 2018 Apr 5.

33.

Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada.

Klimas J, Nosova E, Socías E, Nolan S, Brar R, Hayashi K, Milloy MJ, Kerr T, Wood E.

Drug Alcohol Depend. 2018 May 1;186:182-186. doi: 10.1016/j.drugalcdep.2018.01.027. Epub 2018 Mar 23.

34.

The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.

Ti L, Socías ME, Wood E, Milloy MJ, Nosova E, DeBeck K, Kerr T, Hayashi K.

PLoS One. 2018 Mar 26;13(3):e0194162. doi: 10.1371/journal.pone.0194162. eCollection 2018.

35.

Management of opioid use disorders: a national clinical practice guideline.

Bruneau J, Ahamad K, Goyer MÈ, Poulin G, Selby P, Fischer B, Wild TC, Wood E; CIHR Canadian Research Initiative in Substance Misuse.

CMAJ. 2018 Mar 5;190(9):E247-E257. doi: 10.1503/cmaj.170958. No abstract available.

36.

Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.

Baldwin N, Gray R, Goel A, Wood E, Buxton JA, Rieb LM.

Drug Alcohol Depend. 2018 Apr 1;185:322-327. doi: 10.1016/j.drugalcdep.2017.12.032. Epub 2018 Feb 20. Erratum in: Drug Alcohol Depend. 2019 Apr 1;197:48.

37.

Cannabis use is associated with lower rates of initiation of injection drug use among street-involved youth: A longitudinal analysis.

Reddon H, DeBeck K, Socias ME, Dong H, Wood E, Montaner J, Kerr T, Milloy MJ.

Drug Alcohol Rev. 2018 Mar;37(3):421-428. doi: 10.1111/dar.12667. Epub 2018 Feb 12.

38.

Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.

Kennedy MC, Kerr TH, Wood E, Shoveller JA, Montaner JSG, Milloy MS.

AIDS. 2018 May 15;32(8):1059-1067. doi: 10.1097/QAD.0000000000001777.

39.

Patterns of Non-injection Drug Use Associated with Injection Cessation among Street-Involved Youth in Vancouver, Canada.

Lake S, Kerr T, Nosova E, Milloy MJ, Wood E, DeBeck K.

J Urban Health. 2018 Apr;95(2):267-277. doi: 10.1007/s11524-017-0225-3.

40.

Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.

Klimas J, Dong H, Fairbairn N, Socías E, Barrios R, Wood E, Kerr T, Montaner J, Milloy MJ.

Addict Sci Clin Pract. 2018 Feb 7;13(1):3. doi: 10.1186/s13722-017-0104-y.

41.

Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada.

Beaulieu T, Ti L, Milloy MJ, Nosova E, Wood E, Hayashi K.

Subst Abuse Treat Prev Policy. 2018 Jan 19;13(1):3. doi: 10.1186/s13011-018-0142-9.

42.

Increasing diversion of methadone in Vancouver, Canada, 2005-2015.

Reddon H, Ho J, DeBeck K, Milloy MJ, Liu Y, Dong H, Ahamad K, Wood E, Kerr T, Hayashi K.

J Subst Abuse Treat. 2018 Feb;85:10-16. doi: 10.1016/j.jsat.2017.11.010. Epub 2017 Nov 28.

43.

Evaluating Slow-Release Oral Morphine to Narrow the Treatment Gap for Opioid Use Disorders.

Socías ME, Wood E.

Ann Intern Med. 2018 Jan 16;168(2):141-142. doi: 10.7326/M17-2373. Epub 2017 Dec 26. No abstract available.

44.

Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study.

Goldman-Hasbun J, DeBeck K, Buxton JA, Nosova E, Wood E, Kerr T.

Harm Reduct J. 2017 Dec 22;14(1):79. doi: 10.1186/s12954-017-0206-6.

45.

Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.

Hayashi K, Dong H, Kerr T, Dobrer S, Guillemi S, Barrios R, Montaner JSG, Wood E, Milloy MJ.

J Infect Dis. 2017 Dec 27;217(1):64-68. doi: 10.1093/infdis/jix459.

46.

Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.

Hayashi K, Milloy MJ, Lysyshyn M, DeBeck K, Nosova E, Wood E, Kerr T.

Drug Alcohol Depend. 2018 Feb 1;183:1-6. doi: 10.1016/j.drugalcdep.2017.10.020. Epub 2017 Dec 6.

47.

Socioeconomic factors associated with cessation of injection drug use among street-involved youth.

Chang DC, Hadland SE, Nosova E, Wood E, Kerr T, DeBeck K.

Subst Abuse Treat Prev Policy. 2017 Dec 7;12(1):50. doi: 10.1186/s13011-017-0136-z.

48.

Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions.

Chang DC, Klimas J, Wood E, Fairbairn N.

Am J Drug Alcohol Abuse. 2018;44(2):143-146. doi: 10.1080/00952990.2017.1399403. Epub 2017 Nov 30.

49.

Incidence and predictors of mental health disorder diagnoses among people who inject drugs in a Canadian setting.

Reddon H, Pettes T, Wood E, Nosova E, Milloy MJ, Kerr T, Hayashi K.

Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S285-S293. doi: 10.1111/dar.12631. Epub 2017 Nov 22.

50.

The relationship between hazardous alcohol use and violence among street-involved youth.

Fairbairn N, Wood E, Dobrer S, Dong H, Kerr T, Debeck K.

Am J Addict. 2017 Dec;26(8):852-858. doi: 10.1111/ajad.12643. Epub 2017 Nov 21.

Supplemental Content

Loading ...
Support Center